Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula L McClean

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Alzheimer'S Disease : JAD|June 6, 2026
A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairmentGillian McNaugher, Leah McColgan, Mia Church, et al.
IEEE Journal of Translational Engineering in Health and Medicine|May 13, 2022
Alzheimer's Disease Assessments Optimized for Diagnostic Accuracy and Administration TimeNiamh Mccombe, Xuemei Ding, Girijesh Prasad, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective studyMagda Bucholc, Paula L McClean, Sarah Bauermeister, et al.
IEEE Journal of Biomedical and Health Informatics|July 21, 2021
Practical Strategies for Extreme Missing Data Imputation in Dementia DiagnosisNiamh McCombe, Shuo Liu, Xuemei Ding, et al.
Endocrinology, Diabetes & Metabolism|March 4, 2022
Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK BiobankAndrew R English, Bodhayan Prasad, Declan H McGuigan, et al.
Plos One|February 6, 2013
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's diseaseVadivel Parthsarathy, Paula L McClean, Christian Hölscher, et al.
Diabetes/Metabolism Research and Reviews|February 23, 2007
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amideNigel Irwin, Paula L McClean, Roslyn S Cassidy, et al.
Metabolites|June 21, 2017
Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's DiseaseXiaobei Pan, Christopher T Elliott, Bernadette McGuinness, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|September 10, 2022
Distinguishing Lewy Body Dementia from Alzheimer's Disease using Machine Learning on Heterogeneous Data: A Feasibility StudyNiamh McCombe, Alok Joshi, David P Finn, et al.
Neurobiology of Aging|February 2, 2016
Alzheimer's disease-like pathology has transient effects on the brain and blood metabolomeXiaobei Pan, Muhammad Bin Nasaruddin, Christopher T Elliott, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Alzheimer'S Disease : JAD|June 6, 2026
A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairmentGillian McNaugher, Leah McColgan, Mia Church, et al.
IEEE Journal of Translational Engineering in Health and Medicine|May 13, 2022
Alzheimer's Disease Assessments Optimized for Diagnostic Accuracy and Administration TimeNiamh Mccombe, Xuemei Ding, Girijesh Prasad, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective studyMagda Bucholc, Paula L McClean, Sarah Bauermeister, et al.
IEEE Journal of Biomedical and Health Informatics|July 21, 2021
Practical Strategies for Extreme Missing Data Imputation in Dementia DiagnosisNiamh McCombe, Shuo Liu, Xuemei Ding, et al.
Endocrinology, Diabetes & Metabolism|March 4, 2022
Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK BiobankAndrew R English, Bodhayan Prasad, Declan H McGuigan, et al.
Plos One|February 6, 2013
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's diseaseVadivel Parthsarathy, Paula L McClean, Christian Hölscher, et al.
Diabetes/Metabolism Research and Reviews|February 23, 2007
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amideNigel Irwin, Paula L McClean, Roslyn S Cassidy, et al.
Metabolites|June 21, 2017
Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's DiseaseXiaobei Pan, Christopher T Elliott, Bernadette McGuinness, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|September 10, 2022
Distinguishing Lewy Body Dementia from Alzheimer's Disease using Machine Learning on Heterogeneous Data: A Feasibility StudyNiamh McCombe, Alok Joshi, David P Finn, et al.
Neurobiology of Aging|February 2, 2016
Alzheimer's disease-like pathology has transient effects on the brain and blood metabolomeXiaobei Pan, Muhammad Bin Nasaruddin, Christopher T Elliott, et al.
Pageof 5